BTG Limited, a prominent player in the healthcare industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 1991, the company has established itself as a leader in the development of innovative medical technologies, particularly in the fields of interventional medicine and pharmaceuticals.
Specialising in products that enhance patient outcomes, BTG Limited offers a range of unique services, including targeted therapies for cancer and advanced solutions for vascular conditions. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the medical community.
With a strong market presence and a reputation for excellence, BTG Limited continues to drive advancements in healthcare, making a meaningful impact on patient care worldwide.
+37 vs industry average
BTG Limited’s score of 66 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at BTG Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Reported emissions
No reported emissions data is available for BTG Limited yet.
BTG Limited's reported carbon emissions
BTG Limited, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Boston Scientific Corporation, which cascades its emissions data and climate commitments down to BTG Limited.
As part of its corporate family relationship, BTG Limited adheres to the climate initiatives and targets set by Boston Scientific Corporation. However, specific reduction targets or achievements for BTG Limited are not detailed in the available information.
Boston Scientific Corporation has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its subsidiaries in setting and achieving meaningful emissions reduction goals.
While BTG Limited does not report its own emissions figures, it is aligned with the broader sustainability efforts of its parent company, focusing on reducing its carbon footprint and contributing to climate action within the medical technology industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
BTG Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for BTG Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Boston Scientific Corporation
Carbon Disclosure Project
Inherited from Boston Scientific Corporation
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
BTG Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project